Friday 6 November 2026 Export SYK’s income statement to Excel — free account

Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.

Revenue: +7.64%
EPS: −12.4%
Free cash flow: −19.4%
Total debt: −10.0%

Quarter to September 2026, against a year earlier

324.26 10.82 −3.23%

Follow SYK

Alert me

Market cap: $127.6B
P/E: 35.3×
Fwd P/E: 24.6×
Dividend yield: 1.05%
F-score: 5/9
Altman Z: 4.81
Beneish M: −2.62
Dividend safety: 82/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Stryker Corporation 10-Q filed May 11, 2026

Fiscal Q1 2026 · Period ended Mar 31, 2026 · Filed May 11, 2026 · accepted 11:10 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors: 173 added; every paragraph is new since the annual report